• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
HE Zhaolong,ZOU Yu,CHEN Xia,ZHAO Wenhao,HU Wen,XU Shiqiang.Research progress on biological activity of 1,2,4-benzothiadiazine-1,1-dioxide[J].Journal Of Pharmaceutical Research,2025,44(1):56-65[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2733times   Download 1824次 QR Code for this article
Scan with your phone!
1,2,4-苯并噻二嗪-1,1-二氧化物的生物活性研究进展
何兆龙,邹瑜,陈霞,赵文豪,胡雯,徐诗强
Font:Larger+|Default|Smaller-
(武汉科技大学,湖北 武汉 430065)
摘要:
1,2,4-苯并噻二嗪-1,1-二氧化物的代表性药物氯噻嗪被广泛应用于临床治疗,具有利尿和降压作用。近年来,以1,2,4-苯并噻二嗪-1,1-二氧化物为母核的化合物展现出改善认知功能、抗肿瘤、抗菌和抗病毒等多种药理活性,因此该类化合物已成为当前研究的热点。本文系统总结了近年来1,2,4-苯并噻二嗪-1,1-二氧化物衍生物的国内外研究成果,重点综述了其结构改造和活性研究进展,总结发现1,2,4-苯并噻二嗪-1,1-二氧化物可以作为AMPA和KA受体变构调节剂改善神经功能;对PI3K等癌症相关靶点具有较好的抑制活性;通过抑制HCV NS5B聚合酶发挥抗病毒活性;并且对糖尿病相关疾病靶点如醛糖还原酶,丙酮酸脱氢酶具有较高抑制活性;此外,该类化合物在抗菌、抗虫和抗氧化等方面也有新的研究进展。本文汇总了这些研究成果并分析了其构效关系,旨在为广大研究人员提供研究依据和思路。
关键词:  1,2,4-苯并噻二嗪-1,1-二氧化物  研究进展  中枢神经兴奋作用  抗肿瘤  抗病毒  糖尿病
DOI:10.13506/j.cnki.jpr.2025.01.010
基金项目:国家自然科学基金项目(No.82003593)
Publication Date:January 25, 2025
Research progress on biological activity of 1,2,4-benzothiadiazine-1,1-dioxide
HE Zhaolong,ZOU Yu,CHEN Xia,ZHAO Wenhao,HU Wen,XU Shiqiang
(Wuhan University of Science and Technology,Wuhan 430065,China)
Abstract:
The representative drug of 1,2,4-benzothiadiazine-1,1-dioxide chlorthiazide is widely used in clinical treatment and has diuretic and antihypertensive effects. In recent years, compounds with 1,2,4-benzothiadiazine-1,1-dioxide as the parent nucleus have shown various pharmacological activities such as improvement of cognitive function, anti-tumour, antibacterial and antiviral activities, so this class of compounds has become a hot topic of current research. In this paper, the research achievements of 1,2,4-benzothiadiazine-1,1-dioxide derivatives at home and abroad in recent years were systematically reviewed, with emphasis on the progress of structural modification and activity research. It was concluded that 1,2,4-benzothiadiazine-1,1-dioxide can be used as positive allosteric modulators (PAMs) of AMPA and KA receptors to improve nerve function; it has good inhibitory activity against cancer-related targets such as PI3K; it can inhibit HCV NS5B polymerase to exert antiviral activity; and it has high inhibition activity against diabetes-related disease targets such as aldose reductase and pyruvate dehydrogenase; in addition, the compounds have made new progress in antibacterial, anti-insect and anti-oxidation, this paper summarized these research results and analyzed the structure-activity relationship to provide research basis and ideas for the majority of researchers.
Key words:  1,2,4-benzothiadiazine-1,1-dioxide  Research progress  Central nervous function  Anti-tumor  Antiviral  Diabetes
Today's Visits:509    Total Visits:2383239
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.